Joseph Patrick Cooper - 01 Jan 2023 Form 3/A - Amendment Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Joseph Cooper
Issuer symbol
QNRX
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3/A - Amendment
Filing time
07 Mar 2023, 18:13:33 UTC
Date Of Original Report
03 Jan 2023
Next filing
30 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QNRX Share Option (right to buy) 01 Jan 2023 Ordinary Shares 64,285,600 $0.003500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's original Form 3 incorrectly indicated the options vest in four equal annual installments beginning on April 12, 2023; however, the options vest in three equal annual installments beginning on April 12, 2023.